Rokos Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-87,500
| Closed | -$4.07M | – | 63 |
|
|
2023
Q3 | $4.07M | Hold |
87,500
| – | – | 0.03% | 62 |
|
|
2023
Q2 | $4.9M | Hold |
87,500
| – | – | 0.05% | 59 |
|
|
2023
Q1 | $3.95M | Hold |
87,500
| – | – | 0.29% | 36 |
|
|
2022
Q4 | $3.49M | Hold |
87,500
| – | – | 0.15% | 34 |
|
|
2022
Q3 | $5.87M | Hold |
87,500
| – | – | 0.17% | 41 |
|
|
2022
Q2 | $5.5M | Hold |
87,500
| – | – | 0.16% | 43 |
|
|
2022
Q1 | $5.61M | Buy |
+87,500
| New | +$5.61M | 0.26% | 36 |
|